Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1150 ARTÍCULOS , VIENDO DEL 616 AL 630

Personality factors moderate the associations between apolipoprotein genotype and cognitive function as well as late onset Alzheimer disease

Dar-Nimrod I, Chapman BP, Franks P, Robbins J, Porsteinsson A, Mapstone M, Duberstein PR.

Am J Geriatr Psychiatry. 2012 Dec;20(12):1026-35. doi: 10.1097/JGP.0b013e318267016b.

Physical activity, brain plasticity, and Alzheimer's disease

Erickson KI, Weinstein AM, Lopez OL.

Arch Med Res. 2012 Nov;43(8):615-21. doi: 10.1016/j.arcmed.2012.09.008. Epub 2012 Oct 16.

Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort

Wattmo C, Wallin AK, Minthon L.

BMC Neurol. 2012 Nov 5;12:134. doi: 10.1186/1471-2377-12-134.

Suicide attempt as the presenting symptom of C9orf72 dementia

Synofzik M, Biskup S, Leyhe T, Reimold M, Fallgatter AJ, Metzger F.

Am J Psychiatry. 2012 Nov;169(11):1211-3. doi: 10.1176/appi.ajp.2012.12060733.

Alzheimer's disease: mimics and chameleons

Schott JM, Warren JD.

Pract Neurol. 2012 Dec;12(6):358-66. doi: 10.1136/practneurol-2012-000315.

Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer´s disease - protocol for a controlled, randomized double-blinded trial

Egefjord L, Gejl M, Møller A, Brændgaard H, Gottrup H, Antropova O, Møller N, Poulsen HE, Gjedde A, Brock B, Rungby J.

Dan Med J. 2012 Oct;59(10):A4519.

Practice effects in a longitudinal, multi-center Alzheimer's disease prevention clinical trial

Abner EL, Dennis BC, Mathews MJ, Mendiondo MS, Caban-Holt A, Kryscio RJ, Schmitt FA; PREADViSE Investigators; Crowley JJ; SELECT Investigators.

Trials. 2012 Nov 20;13:217. doi: 10.1186/1745-6215-13-217.

[Nanoparticles for brain delivery of drugs or contrast agents. Application to Alzheimer's disease]

Andrieux K, Couvreur P.

Biol Aujourdhui. 2012;206(3):185-90. doi: 10.1051/jbio/2012019. Epub 2012 Nov 22.

Guidelines for management of idiopathic normal pressure hydrocephalus: second edition

Mori E, Ishikawa M, Kato T, Kazui H, Miyake H, Miyajima M, Nakajima M, Hashimoto M, Kuriyama N, Tokuda T, Ishii K, Kaijima M, Hirata Y, Saito M, Arai H; Japanese Society of Normal Pressure Hydrocephalus.

Neurol Med Chir (Tokyo). 2012;52(11):775-809. doi: 10.2176/nmc.52.775.

[Neuroimaging studies of diabetes and risk of Alzheimer's disease]

Hirano S, Shimada H, Yoshiyama Y.

Brain Nerve. 2012 Dec;64(12):1411-9.

[Imaging diagnosis of Alzheimer's disease]

Mänz C, Reimold M, Bender B, Bares R, Ernemann U, Horger M.

Rofo. 2012 Dec;184(12):1079-82. doi: 10.1055/s-0032-1319030. Epub 2012 Dec 4.

4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia

Gauthier S, Patterson C, Chertkow H, Gordon M, Herrmann N, Rockwood K, Rosa-Neto P, Soucy JP; CCCDTD4 participants.

Can J Neurol Sci. 2012 Nov;39(6 Suppl 5):S1-8. doi: 10.1017/s0317167100015183.

[Alzheimer's disease: are non-steroidal anti-inflammatory drugs effective?]

Peters O.

Dtsch Med Wochenschr. 2012 Dec;137(50):2627. doi: 10.1055/s-0032-1329138. Epub 2012 Dec 5.

[Assessment of benefits of drug therapies: memantine for Alzheimer's disease as an example]

Rüther E, Hellweg R, Janetzky W.

Fortschr Neurol Psychiatr. 2012 Dec;80(12):694-9. doi: 10.1055/s-0032-1312976. Epub 2012 Dec 10.

[Quality of life in dementia: state of the knowledge]

Novella JL, Dhaussy G, Wolak A, Morrone I, Drame M, Blanchard F, Jolly D.

Geriatr Psychol Neuropsychiatr Vieil. 2012 Dec;10(4):365-72. doi: 10.1684/pnv.2012.0375.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias